These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Gait speed in Parkinson disease correlates with cholinergic degeneration. Bohnen NI; Frey KA; Studenski S; Kotagal V; Koeppe RA; Scott PJ; Albin RL; Müller ML Neurology; 2013 Oct; 81(18):1611-6. PubMed ID: 24078735 [TBL] [Abstract][Full Text] [Related]
6. Non-hydrolytic functions of acetylcholinesterase. The significance of C-terminal peptides. Greenfield SA; Zimmermann M; Bond CE FEBS J; 2008 Feb; 275(4):604-11. PubMed ID: 18205834 [TBL] [Abstract][Full Text] [Related]
7. Paradoxical worsening of gait with levodopa in Parkinson disease. Chen R Neurology; 2012 Feb; 78(7):446-7. PubMed ID: 22262745 [No Abstract] [Full Text] [Related]
8. Methylphenidate for gait impairment in Parkinson disease: a randomized clinical trial. Foley PB Neurology; 2011 Dec; 77(23):e140; author reply e140. PubMed ID: 22146929 [No Abstract] [Full Text] [Related]
9. The pathophysiological mechanisms underlying freezing of gait in Parkinson's Disease. Shine JM; Naismith SL; Lewis SJ J Clin Neurosci; 2011 Sep; 18(9):1154-7. PubMed ID: 21724402 [TBL] [Abstract][Full Text] [Related]
10. Macroautophagy of the GPR37 orphan receptor and Parkinson disease-associated neurodegeneration. Marazziti D; Di Pietro C; Golini E; Mandillo S; Matteoni R; Tocchini-Valentini GP Autophagy; 2009 Jul; 5(5):741-2. PubMed ID: 19398891 [No Abstract] [Full Text] [Related]
11. Superficial brain stimulation to overcome freezing of gait in Parkinson disease. Nonnekes J; Janssen S; Bloem BR Neurology; 2017 Apr; 88(17):1681-1682. PubMed ID: 28298547 [No Abstract] [Full Text] [Related]
12. Gait disturbances in advanced stages of Parkinson's disease. Giladi N Adv Neurol; 2001; 86():273-8. PubMed ID: 11553986 [No Abstract] [Full Text] [Related]
14. Spatiotemporal Gait Variables Using Wavelets for an Objective Analysis of Parkinson Disease. Castaño Y; Arango J; Navarro A Stud Health Technol Inform; 2018; 249():173-178. PubMed ID: 29866976 [TBL] [Abstract][Full Text] [Related]
15. [Freezing of gait: clinical problems and therapy]. Defebvre L; Moreau C; Delval A Rev Neurol (Paris); 2009 Apr; 165 Spec No 2():F66-72. PubMed ID: 19593883 [No Abstract] [Full Text] [Related]
16. Understanding and treating freezing of gait in parkinsonism, proposed working definition, and setting the stage. Giladi N; Nieuwboer A Mov Disord; 2008; 23 Suppl 2():S423-5. PubMed ID: 18668629 [No Abstract] [Full Text] [Related]
17. Proposing a new management for freezing of gait in Parkinson's disease. Sarbaz Y; Gharibzadeh S; Towhidkhah F; Banaie M J Neuropsychiatry Clin Neurosci; 2012; 24(3):E48. PubMed ID: 23037684 [No Abstract] [Full Text] [Related]
18. [Diagnostics and therapy of "freezing of gait" in patients with Parkinson's disease]. Amarell M; Cepuran F; Timmermann L; Allert N; Barbe MT Fortschr Neurol Psychiatr; 2014 Oct; 82(10):593-605. PubMed ID: 25299631 [No Abstract] [Full Text] [Related]
19. Attentional set-shifting deficits correlate with the severity of freezing of gait in Parkinson's disease. Shine JM; Naismith SL; Palavra NC; Lewis SJ; Moore ST; Dilda V; Morris TR Parkinsonism Relat Disord; 2013 Mar; 19(3):388-90. PubMed ID: 22906729 [No Abstract] [Full Text] [Related]
20. Real and imaginary gait. Hallett M; Iseki K Mov Disord; 2012 Oct; 27(12):1473-4. PubMed ID: 23008184 [No Abstract] [Full Text] [Related] [Next] [New Search]